Doctors without Borders calls for the rapid availability of bedaquiline in countries with high levels of MDR-TB
Image/CDC In a follow-up to a story earlier this week, the international medical humanitarian organization, Doctors Without Borders/Médecins Sans Frontières (MSF) is calling on the rapid registration of “Sirturo”, More...
Janssen Therapeutic’s ‘Sirturo’ receives FDA approval for treatment of multi-drug resistant pulmonary tuberculosis
This is an anteroposterior (AP) x-ray of a patient’s chest, who was diagnosed with bilateral pulmonary tuberculosis. Image/CDC In a follow-up to a Dec. 1 story, Janssen Therapeutics has announced the U.S. More...
Investigational Multi-Drug Resistant Tuberculosis drug Bedaquiline gets backing from FDA panel
Johnson & Johnson said that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) ruled that its experimental treatment for multidrug-resistant tuberculosis appears to be More...
Johnson & Johnson seeks approval of experimental TB drug bedaquiline
Janssen Research & Development, LLC (Janssen) announced last week it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the More...